Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial.
about
Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm SocietyNon-pharmacological modulation of the autonomic tone to treat heart failurePrediction of heart rate variability on cardiac sudden death in heart failure patients: a systematic reviewImproving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of viewEffects of exercise training on heart rate variability in Chagas heart disease.Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.Influences of age, gender, and circadian rhythm on deceleration capacity in subjects without evident heart diseasesSildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variabilitySerial heart rhythm complexity changes in patients with anterior wall ST segment elevation myocardial infarction.Clinical value of baroreflex sensitivity.2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.Heart rate variability is severely impaired among type 2 diabetic patients with hypertension.Microvolt T-wave alternans and autonomic nervous system parameters can be helpful in the identification of low-arrhythmic risk patients with ischemic left ventricular systolic dysfunction.
P2860
Q26801302-DCD80387-86AD-4E9C-8821-1EDC82F967F0Q26822899-A7BCD846-3F43-4762-9EFF-C84A048C5786Q26858895-AB6D2637-69A1-43EE-A6ED-0AC357CBAFBBQ28079620-1D46ACCC-4AA9-4291-A967-9D22FEC5538EQ34319901-5BE71119-A040-404D-9E96-0EFB5B2B6B5AQ34477958-E7E441D3-5BE8-47EE-A450-8D0FEEA22EBEQ35532491-3B5C4D86-7656-4E20-AFCE-3D6C54219A7FQ36382353-B8554B56-99D0-48CB-9BA0-09C54EA37AE6Q37676378-2A4563D9-E4BE-4D33-9E5F-FF5C0ACD2E60Q42770306-71FED469-6895-4353-A902-C2D1EE4C6D6FQ46502909-A9FE1FF3-F807-4AE9-AF3B-0E94545F0D08Q51723518-F00AF35E-2FAB-435C-8E3A-57D2A4E43A34Q55332528-7B66C4EB-533D-440B-A808-001ABE83D30B
P2860
Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Autonomic markers and cardiova ...... Data from the GISSI-HF trial.
@ast
Autonomic markers and cardiova ...... Data from the GISSI-HF trial.
@en
Autonomic markers and cardiova ...... Data from the GISSI-HF trial.
@nl
type
label
Autonomic markers and cardiova ...... Data from the GISSI-HF trial.
@ast
Autonomic markers and cardiova ...... Data from the GISSI-HF trial.
@en
Autonomic markers and cardiova ...... Data from the GISSI-HF trial.
@nl
prefLabel
Autonomic markers and cardiova ...... Data from the GISSI-HF trial.
@ast
Autonomic markers and cardiova ...... Data from the GISSI-HF trial.
@en
Autonomic markers and cardiova ...... Data from the GISSI-HF trial.
@nl
P2093
P2860
P356
P1476
Autonomic markers and cardiova ...... Data from the GISSI-HF trial.
@en
P2093
GISSI-HF Investigators
Gian Domenico Pinna
Gian Luigi Nicolosi
Marco Veniani
Maria Teresa La Rovere
Marino Bernardinangeli
Roberto Maestri
Roberto Marchioli
Simona Barlera
P2860
P304
P356
10.1093/EURJHF/HFS126
P577
2012-07-30T00:00:00Z